I myself had been a shareholder for many years since back
I myself had been a shareholder for many years since back when the previous management planned to do a Bionic ecig marketing campaign with NASCAR. Eventually through all the debt, dilution and company going nowhere, Mr Allinder became CEO and it appeared that the company was getting cleaned up for real, though at the cost of ongoing massive dilution to shareholders.
Mr Allinder had promised back in 2012 that the company was going through with an audit and would file an audited 10K early in 2013 and I remained a long term shareholder awaiting the day when audited financials would be filed with the SEC. After early 2013 came and went and months later there was still no audited 10K, I eventually was no longer a shareholder.
I have remained positive about RFMK's prospects and potential, however I remain on the sideline until I see real corporate accomplishments. I thought perhaps sometime mid to late 2013 there would be progress but alas there were only more excuses by the CEO.
After seeing the Form 10 though I can see how much time and effort must have had to be put into this process, so as a loyal RFMK follower I can see the difficulties the CEO had to have gone through, both legally and financially. All in all I have a mixed perception of RFMK, I can see the negatives but I can also see the positives. This is only merely my own subjective opinion and my experience as an ex-shareholder in RFMK, so take it with a grain of salt. But I still believe that getting the audited financials and uplisting is truly possible and that if the CEO is doing everything he has claimed to do over the course of 2013 and so far this year that there is potential for corporate progress to be made, and possibly soon, who knows.
I just happen to have decided to remain on the sidelines until actually seeing and reading an audited 10K filed on the SEC (EDGAR) website. Until that day I remain on the sidelines. I am hopeful that the CEO will deliver on promises made but who knows, it may happen or it may not happen, only the CEO really knows what he intends for the future. I think that if audited financials are filed with the SEC it could give HUGE credibility to this real company and I would be intrigued as an investor and it would make me consider once again investing into the company but that is just my own personal opinion.
I think investor confidence was definitely damaged over the last year or so while nothing has really happened other than a launch of two products of which the inventories are no longer getting replenished and promises of audited financials, uplisting and a new product which so far have not been realized or accomplished.
I would agree though that if the CEO can deliver even on only a subset of corporate goals then I would imagine it could bring some much needed value to shareholders.
I guess we shall see what happens in the end.
Do or do not, there is no try.
GLTA!
$RFMK
Rapid Fire Marketing, Inc. (RFMK) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A New Challenge for Miami's Running Scene Mark the date: December 19, 2026. Miami is about to dive headfirst into the madness of the backyard ultra scene. At 8 AM sharp, the inaugural Miami Backyard Ultra kicks off at the Miami Marine Stadium & Basin Trail on Virginia Key, promising a grueling, yet thrilling, test of endurance. It’s like this city’s stepping up with...
Continue Reading
Travel aficionados, pay attention! Hopper's Travel Deal Tuesday is back, and if there's any day to catch a break on your jet-setting costs, it's December 1st. Travel costs have been on a steep incline, with domestic airfares up a whopping 40% over the past year. This year marks the tenth anniversary of Travel Deal Tuesday, and Hopper is pulling out all the stops to save...
Continue Reading
UMG Steps into the Spotlight at Morgan Stanley Event Music, money, and technology—it's a compelling trio. Universal Music Group (EURONEXT: UMG) is sending its heavyweights, Matt Ellis and Michael Nash, to the Morgan Stanley European Technology, Media & Telecom Conference on November 18, 2026. This isn't just any run-of-the-mill industry hobnob. We're talking about the...
Continue Reading
Raytron's Market Supremacy: By the Numbers If you're looking at the thermal imaging sector and wondering what's what, take a clue from Raytron. This outfit isn't just playing the game—it's running the show with a staggering 30% of the global market in 2025. That's right, they hold the medal for leading global shipments in thermal imaging, and unlike many industries...
Continue Reading
This ain't your everyday pat on the back—when Premium Guard Inc. (PGI) snagged the 2027 Top Supplier title from MEMA Aftermarket Suppliers and aftermarketNews, it was a nod to their hustle in the wild world of automotive. Yeah, the guys in Memphis are overachievers, consistently nudging the envelope of car parts. Why Premium Guard Stands Out Let’s be real, it’s not...
Continue Reading
Jing'an's Strategic Moves at 2026 CIIE When you hear "Shanghai," you probably think bright lights, bustling streets, and a city that never sleeps. Now narrow that down even further and you get Jing'an District—a place that's climbing the ladder not just in glitz, but in strategic moves that matter. This year, during the China International Import Expo (CIIE), Jing'an...
Continue Reading
A Fresh Bloom in Gilbert: French Florist Steps In Toss aside your preconceived notions of what a florist shop should be. When French Florist sets up shop, it's not just about selling flowers—they’re a game-changer in the floral industry. As of November 4, they've stamped their luxury mark in Gilbert, Arizona, courtesy of Ronny and Nicole Record, who aren’t your...
Continue Reading
Spicing Up the Holidays with a Best-Seller Return You've got to love when a brand nails it in the holiday treat department, and Day Out Snacks is playing a winning hand by bringing back their Peppermint Bark protein balls. Here we are again, one year after they flew off the shelves like Santa spotted on Christmas Eve. And let me tell you, this re-release has the potential...
Continue Reading
Energy Transition: The New Competitive Edge Forget everything you thought you knew about energy as just a line item in an industry ledger. At the heart of the ongoing COP31 gathering in Antalya, Türkiye, is the revelation that energy has morphed into something greater—it's become the battleground for global competitive advantage. Ali Y. Koç didn't mince words when he...
Continue Reading
Envista on the Move with $430M Notes Ever feel like the market's a bit like a rollercoaster with no brakes? That's kind of where we're at with Envista Holdings Corporation (NYSE: NVST) rolling out this new financial play. They just priced a hefty $430 million in Senior Notes at a solid 6.250% due 2033. In terms of the investment world, that's a pretty big splash. The...
Continue Reading
Top 5 Most Recently Viewed Articles
A Celebration of Veterans and Community Orland Hills is set to light up with a unique Veterans Day Bash on November 1, 2026. This isn't just your run-of-the-mill community gathering; it's an event that brings together veterans from all around for a day packed with resources, education, and a chance to connect with kindred spirits—all thanks to the collaboration between...
Continue Reading
Investors Unite: Important News About Fiserv, Inc. National plaintiffs' law firm Berger Montague is launching an investigation into potential claims against Fiserv, Inc. (NYSE: FI). This inquiry is prompted by allegations of serious securities law violations pertaining to the company's recent business practices. Investors must be informed and proactive about their rights...
Continue Reading
HanAll Biopharma's Batoclimab Receives Orphan Drug Designation In a significant development, Batoclimab has achieved Orphan Drug Designation status, a crucial advancement in the treatment landscape for active Thyroid Eye Disease (TED). This pioneering therapy will enhance accessibility and convenience for patients, allowing them the potential to self-administer the...
Continue Reading
atai Life Sciences Celebrates Milestone in Mental Health Treatment In a significant advancement for mental health treatment, atai Life Sciences has announced that the first patient has been dosed in its Phase 2 clinical trial, Elumina. This trial focuses on VLS-01, a groundbreaking buccal film formulation of N,N-Dimethyltryptamine (DMT), aimed at providing relief for...
Continue Reading
Shell plc Announces Share Buyback News Shell plc, a leading energy company, recently announced a significant move regarding its shares. This initiative involves the purchase of its own shares for cancellation, underscoring the company's commitment to enhancing shareholder value. Details of the Share Purchase During this buyback, Shell purchased a total of 900,000 shares...
Continue Reading